Paired bone marrow and peripheral blood samples demonstrate lack of widespread dissemination of some CH clones. Academic Article uri icon

Overview

abstract

  • Clonal hematopoiesis (CH) represents clonal expansion of mutated hematopoietic stem cells detectable in the peripheral blood or bone marrow through next generation sequencing. The current prevailing model posits that CH mutations detected in the peripheral blood mirror bone marrow mutations with clones widely disseminated across hematopoietic compartments. We sought to test the hypothesis that all clones are disseminated throughout hematopoietic tissues by comparing CH in hip versus peripheral blood specimens collected at the time of hip replacement surgery. Here, we show that patients with osteoarthritis have a high prevalence of CH, involving genes encoding epigenetic modifiers and DNA damage repair pathway proteins. Importantly, we illustrate that CH, including clones with variant allele frequencies >10%, can be confined to specific bone marrow spaces and may be eliminated through surgical excision. Future work will define whether clones with somatic mutations in particular genes or clonal fractions of certain sizes are more likely to be localized or are slower to disseminate into the peripheral blood and other bony sites.

publication date

  • December 1, 2022

Research

keywords

  • Bone Marrow
  • Clonal Hematopoiesis

Identity

Digital Object Identifier (DOI)

  • 10.1182/bloodadvances.2022008521

PubMed ID

  • 36453641